Search results
Is AMC Stock A Buy Now After Roaring Kitty Returns? Meme Stock Soars 308% In May So Far, Retakes Key...
Investor's Business Daily· 13 hours agoIn morning trading on Monday, AMC stock jumped 41% and hit as high as 4.17. At Tuesday's...
Earnings call: Ambu reports robust growth and raises endoscopy guidance
Investing.com· 1 day agoAmbu A/S (AMBU-B.CO), a leading medical device company, has reported strong financial results for...
Why Novavax Stock More Than Doubled Today
Motley Fool via Yahoo Finance· 5 days ago* Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from...
Avalanche hit with brutal Devon Toews update before Game 4
ClutchPoints· 1 day agoThe Colorado Avalanche are hoping to avoid going down 3-1 in their series to the Dallas Stars....
Earnings call: Virios Therapeutics reports on Q1 2024 progress
Investing.com· 3 days agoVirios Therapeutics (NASDAQ: VIRI) discussed their first quarter financial results and provided an ...
2 COVID variants called ‘FLiRT’ are making the rounds: Here are the symptoms
The Patriot-News· 6 days agoA new set of COVID-19 variants are spreading in the U.S. after being detected in wastewater...
Platinum price today: Platinum is up 3.05% year to date
USA Today· 19 hours agoThe chart below shows how the spot price of platinum is trending over the year. The price of XPT/USD...
If You'd Invested $1,000 in Moderna Stock 5 Years Ago, Here's How Much You'd Have Today
Motley Fool via Yahoo Finance· 6 days ago* Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance...
How Is Disney Doing?
Motley Fool via Yahoo Finance· 1 day agoBut again, I guess we're going to have to wait and see because they're going to have to invest a lot of money in the streaming endeavor for some time to...
Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
Morningstar· 5 days ago(NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing innovative immune-oncology technologies addressing hard to treat cancers, today
